Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants.
Wang SC, Yeu Y, Hammer STG, Xiao S, Zhu M, Hong C, Clemenceau JR, Yoon LY, Nassour I, Shen J, Agarwal D, Reznik SI, Mansour JC, Yopp AC, Zhu H, Hwang TH, Porembka MR. Wang SC, et al. Among authors: reznik si. Cancer Res. 2020 Jun 1;80(11):2114-2124. doi: 10.1158/0008-5472.CAN-19-2918. Epub 2020 Apr 8. Cancer Res. 2020. PMID: 32269045 Free PMC article.
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
Karalis JD, Yoon LY, Hammer STG, Hong C, Zhu M, Nassour I, Ju MR, Xiao S, Castro-Dubon EC, Agrawal D, Suarez J, Reznik SI, Mansour JC, Polanco PM, Yopp AC, Zeh HJ 3rd, Hwang TH, Zhu H, Porembka MR, Wang SC. Karalis JD, et al. Among authors: reznik si. J Transl Med. 2022 Mar 7;20(1):116. doi: 10.1186/s12967-022-03317-7. J Transl Med. 2022. PMID: 35255940 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 37865944
Correction to: Lenvatinib inhibits the growth of gastric cancer patient‑derived xenografts generated from a heterogeneous populations.
Karalis JD, Yoon LY, Hammer STG, Hong C, Zhu M, Nassour I, Ju MR, Xiao S, Castro-Dubon EC, Agrawal D, Suarez J, Reznik SI, Mansour JC, Polanco PM, Yopp AC, Zeh Iii HJ, Hwang TH, Zhu H, Porembka MR, Wang SC. Karalis JD, et al. Among authors: reznik si. J Transl Med. 2024 Sep 13;22(1):842. doi: 10.1186/s12967-024-05632-7. J Transl Med. 2024. PMID: 39272170 Free PMC article. No abstract available.
Update on Management of Squamous Cell Esophageal Cancer.
Waters JK, Reznik SI. Waters JK, et al. Among authors: reznik si. Curr Oncol Rep. 2022 Mar;24(3):375-385. doi: 10.1007/s11912-021-01153-4. Epub 2022 Feb 10. Curr Oncol Rep. 2022. PMID: 35142974 Review.
To radiate or not to radiate: that is the question?-a commentary on "Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial".
Chandra R, Reznik SI. Chandra R, et al. Among authors: reznik si. Chin Clin Oncol. 2023 Dec;12(6):60. doi: 10.21037/cco-23-43. Epub 2023 Sep 18. Chin Clin Oncol. 2023. PMID: 37731309 Free article. No abstract available.
53 results